The pupil-size artefact (PSA) across time, viewing direction, and different eye trackers.

Accuracy Eye tracking Gaze estimation Monocular Pupil-size artefact

Journal

Behavior research methods
ISSN: 1554-3528
Titre abrégé: Behav Res Methods
Pays: United States
ID NLM: 101244316

Informations de publication

Date de publication:
10 2021
Historique:
accepted: 09 11 2020
pubmed: 13 3 2021
medline: 21 10 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

The pupil size artefact (PSA) is the gaze deviation reported by an eye tracker during pupil size changes if the eye does not rotate. In the present study, we ask three questions: 1) how stable is the PSA over time, 2) does the PSA depend on properties of the eye tracker set up, and 3) does the PSA depend on the participants' viewing direction? We found that the PSA is very stable over time for periods as long as 1 year, but may differ between participants. When comparing the magnitude of the PSA between eye trackers, we found the magnitude of the obtained PSA to be related to the direction of the eye-tracker-camera axis, suggesting that the angle between the participants' viewing direction and the camera axis affects the PSA. We then investigated the PSA as a function of the participants' viewing direction. The PSA was non-zero for viewing direction 0

Identifiants

pubmed: 33709298
doi: 10.3758/s13428-020-01512-2
pii: 10.3758/s13428-020-01512-2
pmc: PMC8516786
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1986-2006

Informations de copyright

© 2021. The Author(s).

Références

Cesk Oftalmol. 1965 Jan;21:28-35
pubmed: 14330655
PLoS One. 2014 Oct 22;9(10):e111197
pubmed: 25338168
Opt Express. 2010 Oct 11;18(21):22364-76
pubmed: 20941137
Front Psychol. 2013 Dec 24;4:996
pubmed: 24399993
Sci Rep. 2019 Jun 27;9(1):9360
pubmed: 31249360
J Gerontol. 1950 Jul;5(3):216-21
pubmed: 15428618
Vision Res. 2010 Sep 15;50(19):1982-8
pubmed: 20638401
Ophthalmic Physiol Opt. 1988;8(2):178-82
pubmed: 3211558
Behav Res Methods Instrum Comput. 1997 Feb;29(1):54-65
pubmed: 11539868
Front Neuroinform. 2009 Jan 15;2:10
pubmed: 19198666
IEEE Trans Biomed Eng. 1974 Jul;21(4):309-17
pubmed: 4837476
Invest Ophthalmol Vis Sci. 1997 Jun;38(7):1304-13
pubmed: 9191593
Ophthalmic Physiol Opt. 2013 Nov;33(6):634-41
pubmed: 24102513
Vision Res. 2019 Mar;156:1-9
pubmed: 30641092
Vision Res. 1995 Jul;35(14):2021-36
pubmed: 7660606
Vision Res. 2016 Jan;118:48-59
pubmed: 25578924
Behav Res Methods. 2018 Dec;50(6):2480-2497
pubmed: 29508237
J Vis. 2013 May 06;13(6):
pubmed: 23648308
J Neurosci Methods. 2007 May 15;162(1-2):8-13
pubmed: 17254636

Auteurs

Ignace T C Hooge (ITC)

Experimental Psychology, Helmholtz Institute, Utrecht University, Utrecht, The Netherlands. i.hooge@uu.nl.

Diederick C Niehorster (DC)

Lund University Humanities Lab and Department of Psychology, Lund, Sweden.

Roy S Hessels (RS)

Experimental Psychology, Helmholtz Institute, Utrecht University, Utrecht, The Netherlands.

Dixon Cleveland (D)

Eyegaze Inc., Fairfax, VA, USA.

Marcus Nyström (M)

Lund University Humanities Lab, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH